ACTUATE THERAPEUTICS, INC.
Recent Filings
All 154 filings →| Form | Description | Date |
|---|---|---|
| 10-K | FORM 10-K FOR DEC 2025 | Mar 26, 2026 |
| 4 | — | Feb 13, 2026 |
| 8-K | FORM 8-K | Jan 12, 2026 |
| 4 | — | Jan 7, 2026 |
| SCHEDULE 13G | — | Dec 17, 2025 |
| 144 | — | Dec 11, 2025 |
| 8-K | CURRENT REPORT | Nov 28, 2025 |
| 424B5 | SUPPLEMENT TO PROSPECTUS DATED 9-8-25 | Nov 28, 2025 |
| 8-K | FORM 8-K | Nov 21, 2025 |
| 10-Q | FORM 10-Q FOR SEP 2025 | Nov 13, 2025 |
Insider Transactions
View all →| Insider | Title | Type | Shares | Owns After | Date |
|---|---|---|---|---|---|
| Bios Equity COF, LP | — | Purchase | 71,428 @ $7.00 | 196,428 | Jun 27, 2025 |
| BIOS Fund II, LP | — | Purchase | 71,428 @ $7.00 | 196,428 | Jun 27, 2025 |
| BIOS Actuate Co-Invest I, LP | — | Purchase | 71,428 @ $7.00 | 196,428 | Jun 27, 2025 |
| Bios Clinical Opportunity Fund, LP | — | Sale | 5,314 @ $8.00 | 300,143 | Aug 14, 2024 |
| BIOS Capital Management, LP | — | Sale | 17,361 @ $8.00 | 980,433 | Aug 14, 2024 |
| BIOS Fund II, LP | — | Sale | 17,361 @ $8.00 | 980,433 | Aug 14, 2024 |
| Kairos-Actuate SPV, L.P. | — | Sale | 18,750 @ $8.00 | 1,184,795 | Aug 14, 2024 |
| BIOS Equity Partners III, LP | — | Purchase | 375,000 @ $8.00 | 1,259,427 | Aug 14, 2024 |